Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats
- 31 July 2007
- journal article
- Published by Elsevier in Metabolism
- Vol. 56 (7), 931-938
- https://doi.org/10.1016/j.metabol.2007.03.002
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Proposed Mechanisms for the Induction of Insulin Resistance by Oxidative StressAntioxidants and Redox Signaling, 2005
- Long-Term Treatment with Novel Glycogen Synthase Kinase-3 Inhibitor Improves Glucose Homeostasis in ob/ob Mice: Molecular Characterization in Liver and MuscleJournal of Pharmacology and Experimental Therapeutics, 2005
- Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatmentExpert Opinion on Investigational Drugs, 2003
- Insulin Mimetic Action of Synthetic Phosphorylated Peptide Inhibitors of Glycogen Synthase Kinase-3Journal of Pharmacology and Experimental Therapeutics, 2003
- Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase ComplexJournal of Biological Chemistry, 2002
- Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathwaysJournal of Clinical Investigation, 2001
- Cellular mechanisms of insulin resistanceJournal of Clinical Investigation, 2000
- Phosphorylation of Insulin Receptor Substrate-1 on Multiple Serine Residues, 612, 632, 662, and 731, Modulates Insulin ActionJournal of Biological Chemistry, 1996